Archive

Eastern Cape Cancer Patients Affected by Drug Shortage

Eastern Cape cancer patients face a dire situation as treatment interruptions arise from the health department’s payment failures.

Read More

Medical schemes facing ‘slow death spiral’ amid regulatory failures

Explore the impact of medical schemes in South Africa, highlighting gaps in coverage and the rise of supplementary insurance.

Read More

Adcock Ingram’s Lenbucod Blocked by Court Ruling

Adcock Ingram’s Lenbucod blocked by court order over trademark infringement with Aspen’s Mybucod. Learn more about the battle.

Read More

HIV/AIDS Programme Remains Strong Amid Funding Cuts

Discover how South Africa’s HIV/AIDS programme is adapting after US funding cuts. The programme remains on solid ground.

Read More

Public Servant Concerns on Redirecting Medical Aid Contributions

Explore the complexities facing public servants as their medical scheme contributions may be redirected to a National Health Insurance fund.

Read More

NHI Act Court Challenges and Their Implications

Learn about the new NHI act court challenges targeting public participation and constitutionality in South Africa’s healthcare system.

Read More

Adcock Ingram: A picture of resilience in a challenging market

Pharmaceutical stalwart Adcock Ingram presents a compelling case for investors seeking resilience amidst potential market turbulence. The group boasts a robust track record, with a mere 3% dip in headline earnings per share (HEPS) during the challenging Covid-impacted year of 2021. It was their worst annual performance in a decade. Since 2015, Adcock has delivered […]

Read More

Clicks Group: The Value Behind the Price Tag

Clicks Group is undeniably a powerhouse on the JSE. It is widely recognised as a well-managed and resilient business. However, a persistent question dogs potential investors, particularly those inclined towards scepticism: is Clicks Group simply too expensive to justify buying? While it’s true that Clicks trades at a premium compared to many other retailers, this […]

Read More

Ozempic and Mounjaro are reshaping South Africa’s health market

Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.

Read More

Trump targets drug costs in sweeping executive order

Trump targets drug costs with a new executive order to lower prescription prices to align with international rates.

Read More

Ongoing Crisis in Gauteng and the Response from MEC

Gauteng Health and Wellness MEC Nomantu Nkomo-Ralehoko has defended her department, stating there is “no crisis” despite persistent reports of critical issues. These include doctors going unpaid for months and ongoing scrutiny over deep-seated corruption. Some view these issues as part of the ongoing crisis in Gauteng. She asserted that systemic issues had been resolved […]

Read More

SA’s HIV success story creates new challenges

Explore SA’s HIV success story: a transformative treatment programme that increases life expectancy and faces new health challenges.

Read More